| 名稱 | FLT3-ITD D835del/BaF3 |
| 型號 | CBP73241 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | FLT3-ITD [D835del]/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 人乳頭瘤病毒HPV核酸檢測標(biāo)準(zhǔn)品
- 大腦中新發(fā)現(xiàn)的一種淋巴細(xì)胞，能夠清除大腦廢物
- 分子診斷標(biāo)準(zhǔn)品，選擇科佰生物
- 鑒別出促進(jìn)黑色素瘤進(jìn)展的關(guān)鍵蛋白,開發(fā)出新型癌癥靶向療法
- 腫瘤免疫藥靶細(xì)胞模型系列——GITR
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 【產(chǎn)品推介】TMB診斷標(biāo)準(zhǔn)品
- MicroRNA或可特異性地殺死攜帶常見突變的癌細(xì)胞
- GLP1R藥靶篩選模型應(yīng)用展示
- ERBB2基因檢測標(biāo)準(zhǔn)品
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73241FLT3-ITD D835del/BaF3
- 詳細(xì)內(nèi)容
| CBP73241 | |
| I. Introduction | |
Cell Line Name： | FLT3-ITD [D835del]/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+2ug/ml puromycin |
Mycoplasma Status: | Negative |
| II.Background | |
FLT3, receptor-type tyrosine-protein kinase FLT3, activates Akt, Ras, and Erk pathways to regulate differentiation, proliferation, and survival of hematopoietic progenitor cells (PMID: 29316714, PMID: 28538663). Activating mutations of FLT3 are common in hematologic tumors (PMID: 19467916) and the internal tandem duplication (ITD) mutation is commonly observed in acute myeloid leukemia (PMID: 30181385). | |
| III. Representative Data | |
1.FLT3-ITD [D835del]/BaF3
| |
2. Anti-proliferation assay | |
Figure . Anti-proliferation assay of three reference compounds on the FLT3-ITD [D835del]/BaF3 Stable Cell Line. | |
